Deep 6 AI, a California based provider of clinical trials acceleration software, recently secured $17 million in the Series A round of funding.
The round was led by the Point72 Ventures with the participation from strategic partners and GSR Ventures. As a part of this investment, Point72 Ventures partner Daniel Gwak will be going to join as the Deep 6 AI Board of Directors, said the
Deep 6 AI secured $17M in Series A Funding Round
Reviewed by MCH
on
November 28, 2019
Rating:
No comments: